Anna Birna Almarsdóttir

Anna Birna Almarsdóttir

Professor


  1. Published

    Perceived risk of future drugs - a Danish citizen Delphi

    Moldrup, C., Morgall, J. & Almarsdóttir, Anna Birna, Mar 2002, In: Health, Risk & Society. 4, 1, p. 5-17

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    The pleasures and problems of a multi-method multi-disciplinary study: Experiences from an evaluation of a new drug distribution legislation in Iceland

    Morgall, J. M. & Almarsdóttir, Anna Birna, 1999, In: Journal of Social and Administrative Pharmacy. 16, 2, p. 22 1 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Published

    No struggle, no strength: how pharmacists lost their monopoly

    Traulsen, Janine Marie & Almarsdóttir, Anna Birna, May 1999, In: Social science & medicine (1982). 48, 9, p. 1247-58 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The new consumer - Implications for pharmacy

    Traulsen, Janine Marie & Almarsdóttir, Anna Birna, 1 Jan 1999, In: International Journal of Pharmacy Practice. 7, 4, p. 198-201 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Perceived risk of future drugs - A Danish citizen Delphi

    Møldrup, C., Traulsen, Janine Marie & Almarsdóttir, Anna Birna, 2002, In: Health, Risk and Society.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Medically-enhanced normality: An alternative perspective on the use of medicines for non-medical purposes

    Møldrup, C., Traulsen, Janine Marie & Almarsdóttir, Anna Birna, 2003, In: International Journal of Pharmacy Practice. 11, 4, p. 243-249

    Research output: Contribution to journalReviewResearchpeer-review

  7. Published

    Citizen involvement in future drug R&D: A Danish Delphi study

    Møldrup, C., Traulsen, Janine Marie & Almarsdóttir, Anna Birna, 1 Dec 2000, In: Foresight. 2, 5, p. 497-506 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Submitted

    Challenges in the implementation of EU risk minimization measures for medicinal products in clinical practice guidelines: mixed methods multi-case study

    Møllebæk, Mathias, Gardarsdottir, H., Bikou, A., Kodrič, A., Silva , A. M., Andersen, A., Kontogiorgis, C., Poplavska, E., Ahmadizar, F., Dermiki-Gkana, F., Rutkovska, I., Ribeiro-Vaz , I., Kos, M., Sousa Ferreira, P. B., Grupstra , R., Alves, T. L. & Almarsdóttir, Anna Birna, 4 Feb 2024, (Submitted) In: Drug Safety.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. In preparation

    Developing and updating clinical practice guidelines in the European Union: Exploring governance and work processes in six member states

    Møllebæk, Mathias, Almarsdóttir, Anna Birna, Bikou, A., Kodrič, A., Andersen, A., Kontogiorgis, C., Poplavska, E., Ahmadizar, F., Dermiki-Gkana, F., Rutkovska, I., Ribeiro-Vaz , I., Kos, M., Sousa Ferreira, P. B., Grupstra , R., Alves, T. L. & Almarsdóttir, Anna Birna, 2024, (In preparation) In: Health Policy.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Somatic drug profiles in patients diagnosed with Major depression: a Danish nationwide register study using Latent Class Analysis

    Nielsen, A. M. C. O., Jeberg, P. H., Wium-Andersen, M. K., Osler, M., Jacobsen, Ramune, Almarsdóttir, Anna Birna, Jensen, K. J. & Janne, P., 2023. 1 p.

    Research output: Contribution to conferencePosterCommunication

ID: 156729912